ADJUVANS FÜR VAKZINEN

European patent · EP1265633 · Deleted

Register entry

Publication number
EP1265633
Application number
EP01931522
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 14, 2001
Published
Dec 18, 2002
Granted
Dec 12, 2012
Deleted
Mar 31, 2014
Reason
Annual fee unpaid
IPC classes
A61K 39/39 (2006.01)
A61K 39/295 (2006.01)
A61K 39/116 (2006.01)
A61P 37/04 (2006.01)
A61P 31/00 (2006.01)
Priority
DE 10012370 14.03.2000
PCT application
PCT/EP2001/002866 14.03.2001
PCT publication
WO2001/068129 20.09.2001
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 22, 2014

    Deleted, fee unpaid

    Published in Swissreg on 22.10.2014

  2. Dec 29, 2012

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 29.12.2012

  3. Dec 12, 2012

    Granted

    Published in Swissreg on 12.12.2012

Parties

Holder

Novartis Vaccines and Diagnostics GmbH

Emil-von-Behring-Strasse 76, 35041 Marburg, DE

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

BROKER, Michael

35041 Marburg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.